Telomir Pharmaceuticals News and Activities

Telomir Pharmaceuticals is a company listed under the stock ticker TELO (US).

View the org chart displaying its 5 main executives

Most searched biographies at Telomir Pharmaceuticals

• Erez Aminov, Chairman of the Board and Chief Executive Officer
• Matthew Del Giudice, Director
• Matthew Whalen, Director

Popular executive movements at Telomir Pharmaceuticals

• Alan Weichselbaum, Chief Financial Officer, has left the company  (posted on June 9 2026).
• Andriy Mushak has joined the company as Chief Financial Officer  (posted on June 9 2026).

Create your alert
to follow the executive moves at Telomir Pharmaceuticals.

Telomir Pharmaceuticals has 1,913 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).
• Polpharma has acquired Biofarm (posted on June 24 2026).
• AbbVie has announced the acquisition of Apogee Therapeutics  (posted on June 23 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Telomir Pharmaceuticals

• Press Releases - Telomir Pharmaceuticals, Inc. (TELO)
• Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy - Telomir Pharmaceuticals, Inc.
• Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance - T
• News Release - Telomir Pharmaceuticals, Inc. (TELO)
• Press Releases - Telomir Pharmaceuticals, Inc. (TELO)
• News Release - Telomir Pharmaceuticals, Inc. (TELO)
• News Release - Telomir Pharmaceuticals, Inc. (TELO)
• News Release - Telomir Pharmaceuticals, Inc. (TELO)
• News Release - Telomir Pharmaceuticals, Inc. (TELO)
• Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin - Telomir Pharmaceuticals, Inc. (TELO)
• View more press releases Close

Social media about Telomir Pharmaceuticals

• Telomir Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Telomir Pharmaceuticals on LinkedIn, X (Twitter) & YouTube